Surman Timothy L, Stuklis Robert G, Chan Justin C
D'Arcy Sutherland Cardiothoracic Surgery Unit, Royal Adelaide Hospital, Adelaide, S.A., Australia.
Heart Lung Circ. 2019 Mar;28(3):486-494. doi: 10.1016/j.hlc.2018.02.005. Epub 2018 Feb 13.
Multiple case studies have suggested that video-assisted thoracoscopic sympathectomy (VATS) reduces the occurrence and frequency of symptoms in long QT syndrome (LQTS) [1,2,3]. To date there has not been a literature review to report on the short-term and long-term outcomes of this procedure. Our primary aims are to review the literature findings on the clinical outcomes of VATS sympathectomy for long QT and present a local centre case report on the outcomes of T2-T5 sympathectomy.
Relevant articles were identified by a systematic search of PubMed, Cochrane and Scopus databases, from November 1985 to October 2015. A total of 520 patients from 21 publications were included for analysis and discussion in three main areas: presenting symptoms and indication for surgery, perioperative complications, and patient quality of life following surgery. Our case study reviews a 49-year-old female with recently diagnosed long QT syndrome and intolerance to beta blocker therapy successfully managed with T2-T5 thoracic sympathectomy.
The most common presenting indication for operative management of long QT syndrome was syncope (208/520 patients) and tachyarrhythmia (207/520 patients). T1-T5 left sympathectomy was performed in 15/21 published reports (332/520 patients) with partial stellate removal or in its entirety. Follow-up of patients ranged from 1 month to 11 years. Four patients died in the postoperative period, from fatal arrhythmias. The most common postoperative findings were no symptoms (64/520 patients); tachyarrhythmia (55/520 patients), syncope (45/520 patients), and Horner's syndrome (13/520 patients with 27 patients reporting associated symptoms). Thirteen cases reported on the QTc changes post sympathectomy and 9/13 cases involving 220/520 patients showed marked QTc reduction following surgery. Mean preoperative QTc was 558ms and median 559ms. Mean postoperative QTc was 476ms and median 466ms. Our patient showed a marked reduction in QTc following surgery, with no evidence of arrhythmias and reduced beta blocker dependence.
Surgical management of LQTS has historically involved a left cervicothoracic stellectomy removing stellate ganglia and typically part of the left thoracic sympathetic chain resulting in reduction in symptoms but increasing the risk of Horner's syndrome and intermittent temperature changes [4,5]. Surgical resection of the thoracic ganglia alone for management of LQTS is scarce in the literature. Short-term follow-up in our case study following a T2-T5 sympathectomy revealed reduction in symptoms, no requirement for beta blocker therapy and reduced QTc interval. Further follow-up using greater patient numbers will further support T2-T5 sympathectomy as an option for surgical management of LQTS.
多项病例研究表明,电视辅助胸腔镜交感神经切除术(VATS)可降低长QT综合征(LQTS)症状的发生率和发作频率[1,2,3]。迄今为止,尚无文献综述报道该手术的短期和长期疗效。我们的主要目的是回顾关于VATS交感神经切除术治疗长QT综合征临床疗效的文献研究结果,并呈现一个本地中心关于T2 - T5交感神经切除术疗效的病例报告。
通过系统检索1985年11月至2015年10月期间的PubMed、Cochrane和Scopus数据库来识别相关文章。共有来自21篇出版物的520例患者被纳入,在三个主要方面进行分析和讨论:呈现的症状及手术指征、围手术期并发症以及术后患者的生活质量。我们的病例研究回顾了一名49岁女性,她最近被诊断为长QT综合征且不耐受β受体阻滞剂治疗,经T2 - T5胸交感神经切除术成功治疗。
长QT综合征手术治疗最常见的呈现指征是晕厥(208/520例患者)和快速心律失常(207/520例患者)。在15/21篇已发表的报告(332/520例患者)中进行了T1 - T5左侧交感神经切除术,部分或全部切除星状神经节。患者的随访时间从1个月到11年不等。4例患者在术后因致命性心律失常死亡。最常见的术后表现是无症状(64/520例患者);快速心律失常(55/520例患者)、晕厥(45/520例患者)和霍纳综合征(13/520例患者,27例报告有相关症状)。13例报告了交感神经切除术后的QTc变化,9/13例涉及220/520例患者术后显示QTc明显降低。术前平均QTc为558ms,中位数为559ms。术后平均QTc为476ms,中位数为466ms。我们的患者术后QTc明显降低,无心律失常证据且对β受体阻滞剂的依赖减少。
历史上,LQTS的手术治疗涉及左侧颈胸星状神经节切除术,切除星状神经节以及通常部分左侧胸交感神经链,这导致症状减轻,但增加了霍纳综合征和间歇性体温变化的风险[4,5]。文献中单独切除胸神经节治疗LQTS的情况很少。我们的病例研究中T2 - T5交感神经切除术后的短期随访显示症状减轻,无需β受体阻滞剂治疗且QTc间期缩短。使用更多患者进行进一步随访将进一步支持T2 - T5交感神经切除术作为LQTS手术治疗的一种选择。